REJUVENARE, LLC
MAITLAND, FLORIDA

USA certified by the Educational Commission for Foreign Medical Graduates (ECFMG), Since 2005 Dr. Mesples has immersed himself in bioscience research and development to become a leading international expert on the use of autologous bone-marrow SCT (Stem Cell Therapy) for patients suffering from Diabetes Type-1, peripheral vasculopathy and its complications. Rejuvenare’s Scientific Advisor, is a specialist in the biotechnology industry, having worked as an innovator, scientist, advisor, and director for both industry leaders and pioneering start-ups. Dr. Porat served as CTO for TheraVitae, where she established the R&D and manufacturing departments and was responsible for the research, development and production of the company’s GMP-compliant adult stem cell-based products used for preclinical and clinical studies, as well as for routine treatment of patients. Previously, Dr. Porat worked for the global R&D division of Teva Pharmaceutical Industries Ltd (Nasdaq: TEVA) as Manager of the Biological Methods Development department where she lead multidisciplinary research teams in development of biological methods supporting pharmaceutical products development. Prior to Teva, she worked for XTL Biopharmaceuticals Ltd (Nasdaq: XTLB) as a senior project manager and member of the project leaders forum in charge of the company’s strategic planning. Dr. Porat, an author of many scientific publications and patents, holds MA and PhD degrees in Immunology from the Sackler School of Medicine, Tel-Aviv University, Israel. Rejuvenare’s Clinical Research Director / Worldwide Patient Coordinator is an advanced open heart surgery – cardiovascular RN and Age Management nurse practitioner in stem cell therapy, and comes to Rejuvenare with a unique set of talents unmatched anywhere else. Paulene has had years of experience, both as Head Nurse for the Dr. Michael DeBakey team (pioneer in heart transplants), and was the RN and COO of an exclusive off shore stem cell research hospital. She has been sharply focused on wellness and anti aging therapies for decades and continues to apply her knowledge and skills to helping people stay well and youthful. Paulene has been sought after by all the major companies in the stem cell industry and chose Rejuvenare for its integrity-based model. Trained in Rejuvenare’s proprietary stem cell protocols, Paulene is that very special patient advocate who will ensure a very smooth experience from beginning to follow up. Rejuvenare’s Director of Regenerative Advanced Stem Cell Technology is an expert in Cellular Technology and Therapy. Professor Alvarez has over 25 years of experience in the medical field since earning his degree in Medical Technology from the University National Federico Villarreal, School of Medicine in Lima, Peru. He is licensed in Medical Technology, specializing in clinical lab work and pathological anatomy with a Masters in Medical Lab and Public Health. Professor Marco Alvarez is a true pioneer in research and development of the processing and minimal manipulation of the bone marrow since 2002 and was among one of the first people to identify how to treat life altering diseases efficaciously and safely. His work in collaboration with Rejuvenare’s scientific advisory board and medical team has developed proprietary protocols that have conclusively proven to help our patients reclaim their quality of life. Our proprietary cell processing protocols are the result of 15+ years of due diligence and consistent readjustments that have helped over 4,000 patients suffering from heart disease, PAD, Parkinson’s Disease, early dementia, stroke, COPD, and Pulmonary Fibrosis. These autologous personalized cells are unique to every patient and are custom processed to meet therapeutic expectations of each disease. "Before this, I had exhausted every usual solution for a failing heart, including a pacemaker. I continued to worsen. My wife was determined to help me live. She discovered stem cell treatments and researched companies with successful results. This led us to Rejuvenare. "In 2003, Scott was diagnosed with cardiomyopathy. His health deteriorated over the next 8 years to the point his cardiologist gave him little hope. Dying was not an option for Scott. He began researching stem cell therapy and how it was helping folks who had his disease. Through his research he contacted Rejuvenare, and through testing we determined he was a candidate for stem cell therapy. In his own words: My son Carlo is the CEO of Rejuvenare, advanced stem cell therapy. he knew stem cell therapy can often help stroke victims and had my case evaluated by their medical director immediately. My body responded quickly and positively to this nearly painless procedure – and with physical therapy – I quickly regained movement and mental clarity." Is Rejuvenare’s stem cell therapy right for you? Please fill out the following form so that we can contact you for a free consultation. Upon submission, you’ll be redirected for an opportunity to download our patient handbook for more information on Rejuvenare and the therapies that are offered. Is Rejuvenare’s stem cell therapy right for you? Please fill out the following form so that we can contact you for a free consultation. Upon submission, you’ll be redirected for an opportunity to download our patient handbook for more information on Rejuvenare and the therapies that are offered.